Nisha R Acharya Selected Research

Mycophenolic Acid (Cellcept)

1/2022	Comparison of CD4 Counts with Mycophenolate Mofetil versus Methotrexate from the First-line Antimetabolites as Steroid-sparing Treatment (FAST) Uveitis Trial.
1/2022	Time to Uveitis Control with Methotrexate and Mycophenolate Mofetil.
1/2022	Outcomes of Uveitic Macular Edema in the First-line Antimetabolites as Steroid-Sparing Treatment Uveitis Trial.
1/2021	Health- and Vision-Related Quality of Life in a Randomized Controlled Trial Comparing Methotrexate and Mycophenolate Mofetil for Uveitis.
10/2019	Effect of Corticosteroid-Sparing Treatment With Mycophenolate Mofetil vs Methotrexate on Inflammation in Patients With Uveitis: A Randomized Clinical Trial.
7/2017	Quality-of-Life Outcomes From a Randomized Clinical Trial Comparing Antimetabolites for Intermediate, Posterior, and Panuveitis.
1/2017	A Bayesian Analysis of a Randomized Clinical Trial Comparing Antimetabolite Therapies for Non-Infectious Uveitis.
8/2016	Outcomes of Vogt-Koyanagi-Harada Disease: A Subanalysis From a Randomized Clinical Trial of Antimetabolite Therapies.
10/2014	A randomized clinical trial comparing methotrexate and mycophenolate mofetil for noninfectious uveitis.
3/2012	Corticosteroid-sparing therapy: practice patterns among uveitis specialists.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nisha R Acharya Research Topics

Disease

34	Keratitis 01/2020 - 07/2006
33	Ulcer 01/2020 - 09/2009
28	Uveitis 10/2022 - 08/2009
13	Inflammation (Inflammations) 10/2020 - 11/2009
9	Cicatrix (Scar) 01/2019 - 10/2007
8	Macular Edema 01/2022 - 08/2009
7	Infections 10/2022 - 03/2010
7	Panuveitis 10/2019 - 03/2010
7	Corneal Perforation 01/2018 - 06/2010
4	Herpes Zoster 01/2021 - 10/2012
4	Corneal Ulcer 05/2012 - 02/2010
3	Disease Progression 01/2020 - 01/2012
3	Anterior Uveitis 12/2019 - 03/2010
3	Intermediate Uveitis (Chronic Cyclitis) 10/2019 - 03/2010
3	Posterior Uveitis 10/2019 - 03/2010
3	Uveomeningoencephalitic Syndrome (Vogt Koyanagi Harada Syndrome) 08/2016 - 11/2009
3	Acanthamoeba Keratitis 08/2012 - 12/2011
3	Macular Degeneration (Age-Related Maculopathy) 12/2007 - 02/2007
3	Choroidal Neovascularization 12/2007 - 02/2007
2	COVID-19 10/2022 - 01/2022
2	Eye Infections 01/2021 - 08/2012
2	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 10/2020 - 01/2019
2	Necrosis 10/2020 - 10/2012
2	Corneal Injuries 01/2020 - 01/2019
2	Scleritis (Episcleritis) 06/2018 - 01/2017
2	Retinal Detachment (Retinal Detachments) 08/2016 - 11/2009
2	Trachoma 04/2011 - 03/2010
1	Glaucoma 06/2022
1	Hyphema 06/2022
1	Herpes Zoster Ophthalmicus 12/2021
1	Postherpetic Neuralgia 11/2021
1	Birdshot Chorioretinopathy 02/2021
1	Astigmatism 01/2020
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Renal Insufficiency (Renal Failure) 12/2019
1	Neoplasms (Cancer) 06/2018
1	Cataract (Cataracts) 04/2018
1	Sarcoidosis (Schaumann Disease) 01/2018
1	Pseudomonas Infections 09/2016
1	Low Vision (Subnormal Vision) 07/2016
1	Foreign Bodies (Foreign Body) 10/2015

Drug/Important Bio-Agent (IBA)

29	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2022 - 08/2009
25	SteroidsIBA 01/2022 - 09/2009
16	Voriconazole (Vfend)FDA LinkGeneric 01/2020 - 06/2007
15	Natamycin (Pimaricin)FDA Link 01/2020 - 06/2007
10	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2022 - 03/2012
10	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 03/2012
9	Moxifloxacin (Avelox)FDA Link 06/2014 - 01/2012
7	AntimetabolitesIBA 01/2022 - 08/2016
6	Anti-Bacterial Agents (Antibiotics)IBA 07/2016 - 03/2008
5	prednisolone phosphate FDA LinkGeneric 02/2014 - 02/2012
5	Ranibizumab (Lucentis)FDA Link 10/2011 - 02/2007
3	RNA (Ribonucleic Acid)IBA 06/2022 - 04/2018
3	Herpes Zoster VaccineIBA 12/2021 - 01/2021
3	VaccinesIBA 11/2021 - 01/2021
3	Prednisone (Sone)FDA LinkGeneric 10/2019 - 06/2010
3	Infliximab (Remicade)FDA Link 04/2014 - 06/2010
3	Amphotericin B (Amphotericin)FDA LinkGeneric 05/2011 - 06/2007
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2022 - 10/2020
2	Adalimumab (Humira)FDA Link 10/2020 - 02/2012
2	SolutionsIBA 12/2019 - 08/2012
2	ORALIT (ORS)IBA 04/2018 - 03/2010
2	Ophthalmic Solutions (Eye Drops)IBA 01/2018 - 12/2016
2	Antifungal AgentsIBA 12/2016 - 12/2016
2	Fluorescein (Funduscein)FDA LinkGeneric 10/2015 - 09/2013
2	FluoroquinolonesIBA 04/2014 - 03/2013
1	HLA-A29 antigenIBA 02/2021
1	HLA Antigens (Human Leukocyte Antigens)IBA 02/2021
1	Nucleic AcidsIBA 01/2021
1	durvalumabIBA 01/2020
1	Valganciclovir FDA Link 12/2019
1	Ganciclovir (Cytovene)FDA LinkGeneric 12/2019
1	prednisolone acetate FDA LinkGeneric 10/2019
1	Pharmaceutical PreparationsIBA 10/2019
1	Triamcinolone (Aristocort)FDA Link 01/2019
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2019
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2019
1	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 01/2019
1	NivolumabIBA 06/2018
1	cabiralizumabIBA 06/2018
1	Attenuated VaccinesIBA 05/2018
1	Subunit VaccinesIBA 05/2018
1	EnzymesIBA 01/2018
1	difluprednate FDA Link 01/2018
1	Muramidase (Lysozyme)IBA 01/2018
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2018
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	Virulence Factors (Pathogenicity Factors)IBA 04/2016

Therapy/Procedure

21	Therapeutics 12/2019 - 08/2009
7	Penetrating Keratoplasty 01/2018 - 04/2013
5	Injections 03/2021 - 08/2009
4	Contact Lenses 01/2020 - 04/2012
4	Immunomodulation 10/2019 - 03/2012
2	Aftercare (After-Treatment) 01/2019 - 03/2010
1	Intraocular Lenses (Intraocular Lens) 06/2022
1	Meridians (Jing Luo) 01/2019
1	Slit Lamp 01/2019
1	Immunotherapy 06/2018
1	Corneal Transplantation (Keratoplasty) 01/2017